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ABSTRACT
The study sought to identify determinants of blood loss at childbirth and 24 hours postpartum. The study 
was nested in a community-based randomized trial of treatments for anaemia during pregnancy in Wete 
Town, Pemba Island, Zanzibar, United Republic of Tanzania. Status of anaemia during pregnancy, nutri-
tional information, obstetric history, and socioeconomic status were assessed at enrollment during rou-
tine antenatal care. Pregnant women presented for spontaneous vaginal delivery, and nurse-midwives 
collected information on labour and delivery via partograph. Blood-stained sanitary napkins and pads 
from childbirth and 24 hours postpartum were quantified using the alkaline hematin method. Moderate-
to-severe anaemia (Hb <90 g/L) at enrollment was strongly associated with blood loss at delivery and the 
immediate postpartum period, after adjusting for maternal covariates and variables of biological relevance 
to blood loss. Greater blood loss was associated (p<0.10) with duration of the first stage of labour, placental 
weight, receipt of oxytocin, preterm birth, and grand multiparity. The findings provide unique evidence 
of a previously-suspected link between maternal anaemia and greater blood loss at childbirth and post-
partum. Further research is needed to confirm these findings on a larger sample of women to determine 
whether women with moderate-to-severe anaemia are more likely to experience postpartum haemorrhage 
and whether appropriate antenatal or peripartum care can affect the relationships described here.  
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INTRODUCTION
Over half a million women die due to complica-
tions of pregnancy and childbirth each year (1). In 
sub-Saharan Africa where the majority of maternal 
deaths occur, the risk of dying in childbirth is 175 
times that of developed countries (2). Postpartum 
haemorrhage, characterized by severe bleeding 
(>500 mL) after birth of the baby, is the leading 
cause of maternal death in African and other de-
veloping countries (3). Childbirth and the imme-
diate postpartum period are critical time points in 
a woman’s life, as maternal deaths primarily occur 
during labour, delivery, and the immediate postpar-
tum period, with the risk of death being particularly 
high in the initial days following birth (4). Further, 
in addition to the devastating impact of maternal 
mortality due to postpartum haemorrhage, mil-
lions of women survive postpartum haemorrhage Kavle JA et al. Anaemia during pregnancy and blood loss at delivery
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and continue to suffer from its debilitating con-
sequences, including chronic illness, disability, an 
increased risk of death and/or poor growth and de-
velopment of their children (5). 
Despite the global significance of postpartum 
haemorrhage, little is known about factors that 
contribute to postpartum haemorrhage, especially 
in less-developed areas where 99% of maternal 
deaths occur. Severe anaemia may weaken uterine 
muscular strength or lower resistance to infectious 
diseases, contributing to postpartum haemorrhage 
and subsequent maternal mortality (6,7). However, 
the severity of anaemia that places a woman at a 
greater risk of experiencing postpartum haemor-
rhage or a debilitating and clinically relevant blood 
loss has not been investigated. Indeed, the impact 
of anaemia on the extent of blood lost at childbirth 
and postpartum is not well-understood. 
Previous studies, conducted largely in non-anaemic 
populations, identified nulliparity, grand multipari-
ty, obesity, birthweight of >4,000 g, lacerations/tears, 
episiotomy, delivery using forceps, pre-eclampsia, 
multiple gestation, premature birth, advanced age, 
short stature, induced labour, and augmented la-
bour as risk factors for postpartum haemorrhage 
(8-15). Two previous studies among African popu-
lations reported no association between maternal 
anaemia and postpartum haemorrhage in Nigeria 
(8) and no difference in risk of postpartum haem-
orrhage between severe and non-severe anaemia 
among Ghanaian women (9). In contrast, cases of 
postpartum haemorrhage in Zimbabwe were 2.2 
times more likely to have haemoglobin levels of 
<120 g/L than those of non-postpartum haemor-
rhage controls (10). However, these studies have not 
described the procedures of measurement of anae-
mia/haemoglobin and relied on visual estimation 
or measurement from a basin combined with visual 
estimation, techniques that can underestimate or 
imprecisely ascertain blood loss (8-10,16,17). To 
date, no investigations have measured blood loss 
at delivery and the immediate postpartum period, 
apart from the extremes of blood loss (postpartum 
haemorrhage), and examined pregnancy and child-
birth determinants of blood loss.
In this study in Pemba Island, Zanzibar, United 
Republic of Tanzania, we examined the relation-
ships between nutritional, obstetrical and socioeco-
nomic factors and blood loss during childbirth and 
the postpartum period. Specifically, we evaluated 
whether maternal anaemia contributes to greater 
blood loss at childbirth and 24 hours postpartum.
MATERIALS AND METHODS
Pemba Island is one of two main islands which 
comprises  the  archipelago  known  as  Zanzibar, 
United Republic of Tanzania. Agriculture and fish-
ing  are  the  primary  occupations,  and  the  major 
cash crop is clove. The population is predominant-
ly Muslim and of Bantu and Omani Arab ethnic 
origin. Plasmodium falciparum malaria and hook-
worm infection are endemic in the island (18,19). 
The typical diet consists of cassava and rice mixed 
with seasonally-available vegetables and fish; there 
is infrequent intake of meat due to poor availability 
and high cost (20).
This investigation was part of a larger randomi-
zed trial—“Mothers and Health”—in which the 
effectiveness of the World Health Organization- 
recommended Standard Care for the prevention 
and treatment of severe anaemia in pregnan-
cy was compared with an enhanced regimen. 
Eight antenatal clinics were randomly allocated 
to Standard Care and Enhanced Care by coin toss 
with strata defined by geographical location. Inves-
tigators, study personnel, and participants were 
unmasked to treatments. All women received iron-
folate supplements (60 mg iron and 400 µg folate, 
per tablet, daily), sulphadoxine-pyrimethamine, an 
antimalarial drug (500 mg sulphadoxine and 25 mg 
pyrimethamine, per tablet, 2 doses, 4 weeks apart), 
and mebendazole, a deworming (Standard Care: 
one 500-mg dose; Enhanced Care: 100 mg, twice a 
day for 3 days, 2 doses, 8 weeks apart). Women in 
the Enhanced Care group received a daily multi-
vitamin  containing  recommended  dietary  allow-
ances of: vitamin A, 5,000 IU; vitamin E, 30 IU; 
vitamin C, 60 mg; vitamin D, 400 IU, thiamin, 1.5 
mg, riboflavin, 1.7 mg, niacin, 20 mg; vitamin B6, 
2 mg; folic acid, 400 µg; vitamin B12, 6 µg; and 
pantothenic acid, 10 mg. 
At the baseline clinic visit, women with haemoglo-
bin (Hb) concentration of <70 g/L received a double 
dosage of iron-folate tablets as per the international 
guidelines for iron-deficiency anaemia (21). Further 
details of study design, data collection, and clinical 
assessments are described elsewhere (22).   
The sample size, based on a correlation (r=-0.20) 
between Hb status and blood loss, with α=0.05 and 
β=0.20, and a loss to follow-up of 15%, was de-
termined to be 240 women. The first 256 eligible 
pregnant women attending two public antenatal 
clinics in Wete town from 13 April 2004 to 28 July 
2004 were invited to participate in the ‘Blood Loss’ 
sub-study at baseline antenatal visit. The inclusion Kavle JA et al. Anaemia during pregnancy and blood loss at delivery
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criteria included: women who sought routine an-
tenatal care at study clinics, resided within desig-
nated study areas in Wete town, and who planned 
to have a spontaneous vaginal delivery with gov-
ernment hospital admission until 24 hours post-
partum. Women presenting for cesarean delivery 
were excluded upon hospital admission. The final 
sample consisted of 158 women due to loss to fol-
low-up as these women had either delivered prior 
to obtaining a blood sample, could not arrive at 
the hospital on time for delivery, or did not stay 
through the 24 hours postpartum for collection of 
complete data on blood loss.
All the participants were provided with a safe de-
livery-kit containing gloves, needles and syringes, 
ergometrine, oxytocin, sutures, gauze, and cotton. 
Additionally, each participant received a large pad 
to replace the plastic sheet normally used at deliv-
ery. Following delivery, sanitary pads and white un-
derwear were distributed for collection of secreted 
postpartum blood.  
Nurses at the antenatal clinic and study staff col-
lected information on nutritional (weight, height) 
and socioeconomic variables (e.g. household pos-
sessions, educational level) at baseline. Parity was 
defined as the number of previous births. For 
analyses, parity was categorized into four groups: 
nulliparous, 0 previous birth (reference category), 
primiparous (1 previous birth), multiparous (2-5 
previous births), and grand multiparous ( > 5 previ-
ous births). 
The study nurses collected blood samples (5 mL) 
by venipuncture in heparinized Vacutainer tubes 
at baseline and 34-36 weeks gestation. Zinc pro-
toporphyrin was measured by haematoflourome-
tre. Drops of whole blood were dispensed to make 
thick malaria blood films at baseline and 36 weeks 
gestation and to determine haemoglobin concen-
trations at baseline, 32 weeks, and 36 weeks ges-
tation. Women with severe anaemia (Hb <70 g/L), 
were asked to return to the clinic one week and 
four weeks post-baseline for clinical evaluation of 
improvement in haemoglobin concentrations and 
hospital referral, if needed. Malaria smears were 
fixed in alcohol and stained with Giemsa, and the 
number of malaria parasites was counted against 
leucocytes. Faecal samples were examined for hel-
minth infection using the Kato Katz method (23).
For collection of secreted blood at delivery and 
postpartum, a hospital setting was chosen for ease 
in collection and storage of pad samples. The time-
frame of data collection (24 hours following the 
time of delivery) followed the American College of 
Obstetrics and Gynecology and World Health Or-
ganization’s definition of early postpartum haem-
orrhage (3,24).
A large thin absorbent white pad was placed un-
derneath the woman following pelvic examination 
to confirm full dilation. Ergometrine maleate (0.5 
mg/mL) was routinely given as part of active man-
agement of the third stage of labour, after the birth 
of the baby.  As part of hospital protocol, oxytocin 
(1, 2, 3, or 5 IU) was administered to either aug-
ment labour or reduce excessive bleeding. Gauze, 
cotton, and white gloves were used for mopping up 
excessive blood loss at delivery. Following placental 
delivery, the nurses held the placenta to collect ma-
ternal blood onto the delivery pad and weighed the 
placenta using a scale. Secreted blood at childbirth 
was collected from full dilation until delivery of the 
placenta.  
Postpartum collection of secreted blood com-
menced after the third stage of labour and ended 
at 24 hours post-delivery. Immediately following 
the removal of delivery pad, the nurses and or-
derlies initially assisted women for the collection 
of postpartum blood. Orderlies provided women 
with sanitary pads and white cotton underwear for 
the remaining 24 hours, which were collected in 
Stomacher bags and placed in a cooler after each 
collection. All delivery and postpartum samples 
were transferred to the hospital laboratory. Blood 
loss was measured using the alkaline hematin tech-
nique (22,25).
Two litre of a 5% sodium hydroxide solution (J.T. 
Baker, Phillipsburg, NJ, USA) was added to each 
pad sample. Samples were then placed in the Stom-
acher Blender (Seward Company, Norfolk, UK) for 
15 minutes. The automated paddles of the blender 
facilitated breakdown of pad material and conver-
sion of haemoglobin to an alkaline hematin solu-
tion, which was decanted into a glass beaker. The 
weights of all materials added to Stomacher bags 
were subtracted from calculations of total blood 
loss. Further details on quantification methods of 
blood loss are described elsewhere (22,25).
Ethics 
The human subject review committees at the Johns 
Hopkins University Bloomberg School of Public 
Health, Baltimore, Maryland, USA, Cornell Uni-
versity, Ithaca, New York, USA, and the Zanzibar 
Research Council, United Republic of Tanzania, in-
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Statistics 
To evaluate anaemia during pregnancy, we used 
haemoglobin cut-offs: 110 g/L, 105 g/L, and 110 
g/L for baseline, 32 weeks, and 36 weeks gestation 
respectively. ‘Moderate’-to-‘severe’ anaemia was 
defined as Hb <90 g/L. Additionally, we evaluated 
zinc protoporphyrin—an indicator of iron deficien-
cy—using an international cut-off for iron-deficient 
erythropoiesis measured by erythrocyte protopor-
phyrin as >70 µmol/mol heme (26). Erythrocyte 
protoporphyrin usually exists as zinc protoporphy-
rin, the major molecular form of erythrocyte pro-
toporphyrin (27).
We computed compliance with iron-folate and 
multivitamin supplementation, mebendazole (one 
dose or two doses), and Fansidar (baseline and/or 
four weeks after baseline). Home monitors counted 
the ‘number of pills remaining’ for iron or iron plus 
multivitamin pills per bi-weekly period until child-
birth. We calculated ‘percent compliance’ for iron 
and multivitamins (restricting computations from 
enrollment until childbirth) using the following 
formula: 
Total number of pills given until childbirth –   
total number of pills remaining
Total number of pills given to women from   
enrollment until childbirth
In our analysis, we explored nutritional, obstetrical 
and socioeconomic factors as determinants of blood 
loss. We examined the relationships between total 
blood loss (millilitre of blood loss at childbirth and 
postpartum) and factors previously reported to be 
associated with postpartum haemorrhage. We used 
simple linear regression, Wilcoxon rank sum, and 
Kruskal-Wallis tests for bivariate analyses. Specifi-
cally, to determine the relationship among mater-
nal anaemia, iron deficiency, and total blood loss, 
we considered the relationship between total blood 
loss and measures of iron status, including anaemia 
and found a linear specification to be appropriate. 
Then, we assessed the relationship between catego-
ries of severity of anaemia and zinc protoporphyrin 
levels and total blood loss. The relationships with 
changes in haemoglobin values from recruitment 
to 36 weeks gestation were also evaluated. 
For our multivariate analyses, each variable was 
evaluated and retained in the model based on the 
strength of association with blood loss, as ascer-
tained by p value. Variables identified in previous 
investigations and/or had biological relevance to 
blood loss at childbirth were retained in our model.   
For example, the presence of an episiotomy or vagi-
nal tear was retained in our final model due to prior 
consistent associations of blood loss with perineal 
lacerations or operative episiotomy. For variables 
with more than two categories, a series of dummy 
variables were created (e.g. parity). Variables asso-
ciated with total blood loss (mL), at p<0.10, were 
included in our final model. A higher alpha value 
allowed for adequate examination of all related de-
terminants, which would otherwise be restricted at 
lower values (e.g. p<0.05). 
RESULTS
The median age of participants was 25.5 years, and 
the median gestational duration was 29.0 weeks (Ta-
ble 1). The majority (63.2%) of women were multip-
arous, with 37% of women reporting 2-5 previous 
pregnancies and 26% of women reporting >5 pre-
vious pregnancies. Women had relatively low 
rates of intestinal helminth infection, most like-
ly due to schistosomiasis and filariasis-deworming 
campaigns (25-26 April 2004 and 18-19 October 
2003 and 2004 respectively) that distributed 
albendazole and ivermectin to all non-pregnant 
Zanzibari adults.   
All were singleton spontaneous deliveries, with the 
exception of three women who delivered twins 
(Table 2). Most (95.6%) women received ergome-
trine, and about a half received oxytocin in the 
third stage of labour. Our data revealed a low rate of 
tears and episiotomy. The average birthweight was 
3,410+434 g.  
Our findings revealed that 75% of women with Hb 
<110 g/L had the zinc protoporphyrin values of 
>70 µmol/mol, indicative of iron-deficient erythro-
poiesis and presumably iron deficiency. Moreover, 
all women with Hb <90 g/L had the zinc proto-
porphyrin values of >70 µmol/mol. The intensity 
of hookworm infection was negatively associated 
with Hb (p<0.01).  
Women were compliant with the iron-folate and 
multivitamin supplements, on 95.4% and 97.9% 
of days respectively. Less than half of the par-
ticipants were given Fansidar (39.0% at baseline 
and 42.0% at second dosing, four weeks post-
baseline) due to self-reported sulpha drug allergies, 
gestational age >34 weeks, or early pregnancy (no 
evidence of foetal movement or foetal heartbeat 
or fundal height less than 16 weeks gestation). Ap-
proximately 92.4% of the women took one dose of 
mebendazole during the course of the study. Of the 
Enhanced Care enrollees, 96.1% received a second 
dose of mebendazole, eight weeks post-baseline. Kavle JA et al. Anaemia during pregnancy and blood loss at delivery
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In bivariate analyses, increased blood loss at child-
birth and postpartum was strongly associated with 
the severity of maternal anaemia at enrollment 
(p=0.02) and at 32 weeks gestation (p=0.03) (Table 
3). The change in haemoglobin concentration 
from recruitment to 36 weeks gestation was not as-
sociated with total blood loss. 
Increased total blood loss was also associated with 
the greater duration of the first stage of labour 
(p=0.02), receipt of oxytocin during the third stage 
of labour (p=0.06), and first—degree tear at childbirth 
(p=0.08). Women with tears (p=0.08) experienced 
greater losses than women without any trauma at 
delivery. Blood loss was lower among those deliver-
ing preterm (<37 weeks gestation) (p=0.01). These 
data are not presented in tabular form.
In multivariate analysis, women with moderate-to-
severe anaemia at enrollment had a significantly 
greater total blood loss (91 mL) average compared 
to non-anaemic women (p<0.01) (Table 4). Blood 
loss was slightly elevated in mild anaemic women 
compared to non-anaemic women; however, 
this association was not statistically significant. 
Greater blood loss was associated with an increased 
duration of the first stage of labour (p=0.01), greater 
placental weight (p=0.03), and receipt of oxytocin 
with ergometrine (p=0.05) (Table 4). The latter as-
sociation could be due to the use of oxytocin to 
reduce bleeding in diagnosed cases of postpartum 
haemorrhage. Also, a lower dosage of oxytocin was 
administered to women, as 73% received 1 IU in-
stead of the 10 IU normally given. Suboptimal dos-
ing was unlikely to reduce blood loss effectively. 
Preterm birth was associated with decreased blood 
loss (p=0.08) compared to deliveries at term. Primipa- 
rous and multiparous women had blood losses of 
similar magnitude, yet grand multiparous women 
experienced the greatest blood loss (p=0.09) com-
pared to nulliparous women.  
Treatment assignment was not associated with 
blood loss, and there was no evidence for interac-
tion between treatment assignment and baseline 
haemoglobin on the level of blood loss.
DISCUSSION
Our most salient finding in this study is a strong 
association between moderate-to-severe anaemia at 
28 weeks gestation (on average) and greater sever-
ity of blood loss at delivery and postpartum. This 
association is noteworthy because it persisted after 
adjustment for confounding factors, including la-
bour and delivery variables, placental size, obstetric 
history, socioeconomic status, and treatments of 
anaemia. The association persisted at 32 weeks ges-
tation, but not at 36 weeks gestation.
Table 1. Selected characteristics of 158 Zanzibari 
women at enrollment
Baseline characteristics 50th (5th, 95th) or %
Age (years) 25.5 (18.0, 38.0)
Gestational age (weeks) 29.0 (20.0, 37.0)
Trimester
  Second 18.4
  Third 81.6
Maternal weight (kg) 59.6 (45.2, 83.2)
Maternal height (cm) 155.6 (147.6,167.0)
Maternal BMI (kg/m2) 24.4 (19.1, 34.1)
Haemoglobin (g/L) 105 (79, 140)
Haemoglobin category 
   (g/L)
No anaemia >110 38.6
Mild anaemia 90-109 45.6
Moderate—severe anae-
mia  <90
15.8
Parity (%)
  0 21.5
  1 15.2
  2-5 37.3
  >5 25.9
Malarial infection (%)  3.8
Intestinal helminth infec-
tion* (%)
Trichuris 26.5
Hookworm 13.9
Ascaris 2.0
Employment (%)
   No  80.4
   Yes 19.6
Education (%)
   No school 3.2
   Quranic school only 9.5
   Completed some primary 
education 17.1
   Completed primary edu-
cation 17.1
   Secondary, form 1-4 52.5
   Secondary, form 5-6  0.6
Possession of household 
items (%)
    Radio 79.7
    Bicycle 57.0
*7 missing, n=151 for helminth variables; BMI=Body 
mass indexKavle JA et al. Anaemia during pregnancy and blood loss at delivery
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Our bivariate data suggest increased total blood 
losses with elevated zinc protoporphyrin, particu-
larly at values of 70 µmol/mol heme or greater. Zinc 
protoporphyrin is a measure of iron deficiency, and 
most women with Hb <90 g/L had elevated zinc 
protoporphyrin as did the majority of women with 
Hb <110 g/L. It is true, however, that the zinc pro-
toporphyrin values are also elevated with infection, 
malaria, and haemoglobinopathies, e.g. sickle-cell 
anaemia (27-30), and elevated zinc protoporphyrin 
and, thus, does not confirm that our association is 
restricted to those with iron-deficiency anaemia. 
We found no effect of treatment of anaemia on to-
tal blood loss, as both the treatment groups showed 
similar blood losses and haemoglobin concentra-
tions. Further, we found no significant difference 
by treatment group in the change in haemoglobin 
from enrollment (28 weeks gestation on average) 
to 36 weeks gestation. All participants received the 
same dose of iron and folic acid; therefore, any ad-
Table 2. Selected labour and delivery character-
istics of 158 Zanzibari women
Characteristics at child-
birth
50th (5th, 95th) 
percentile or %
Received any oxytocin (%) 44.9
Received any ergometrine (%) 95.6
Received both ergometrine 
and oxytocin (%) 40.5
Tear (%)   7.6
Episiotomy (%) 16.5
Duration (hours) of labour 
   Nulliparous 11.0 (5.8, 22.5)
   Primiparous 8.0 (5.8, 15.9)
   Multiparous 6.8 (3.2, 15.4)
   Grand multiparous 6.5, (4.4, 13.8)
Gestational age (weeks) 39.1 (36.4, 43.5)
Birthweight (g)* 3,410+434
*Mean+SD, calculated for singleton births only 
(n=155); SD=Standard deviation
Table 3. Associations of anaemia during pregnancy and iron deficiency with total blood loss in 
158 Zanzibari women
Anaemia during pregnancy and iron deficiency as 
determinants of blood loss 
p value
Median volume (mL) of 
blood lost at childbirth 
and postpartum (25th, 75th 
percentile)
Baseline haemoglobin*, n=158          
  >110 g/L, n=61
  90-109 g/L, n=72
  <90 g/L, n=25
0.02
218 (155, 303)
247 (168, 300)
301 (222, 441)
Change in haemoglobin from recruitment 
to 36 weeks gestation* (g/L) by quartile, n=137    
  -50 to -2.0, n=36
  -2.0 to 5.0, n=38
  5.0 to 16, n=35
  16 to 60, n=38
0.58
216 (152, 312)
230 (161, 296)
272 (187, 412)
267 (204, 327)
Baseline ZPP†  (μmol/mol heme), n=158 
   <70, n=44
   >70, n=114
0.30
224 (162, 299)
262 (176, 329)
32 week haemoglobin*, n=85
  >105 g/L, n=44
  90-104 g/L, n=35
  <90 g/L, n=6
0.03
194 (134, 280)
252 (211, 325)
314 (135, 373)
36 week hemoglobin*, n=137       
  >110 g/L, n=74  
  90-109 g/L, n=56 
  <90 g/L, n=7
0.71
249 (170, 321)
238 (163, 317)
311 (135, 441)
Treatment group‡  n=159  
  Standard Care, n=77
  Enhanced Care, n=81  
0.37
256 (187, 325)
248 (150, 321)
*Kruskal-Wallis non-parametric test; †Simple linear regression; ‡Wilcoxon Rank sum test; 
ZPP=Zinc protoporphyrinKavle JA et al. Anaemia during pregnancy and blood loss at delivery
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ditional benefit conferred by the treatment group 
would be due to the multivitamins received by 
women in the Enhanced Care group. The fact that 
the association was the strongest among those in 
mid-pregnancy might suggest that our results are 
due to plasma volume expansion, if women with 
greater haemodilution (and lower haemoglobin 
concentrations) during mid-pregnancy experience 
more blood loss. A greater understanding of the 
influence of biological pathways on blood loss at 
childbirth and postpartum will be required to re-
fine our interpretations.
Several biological mechanisms are thought to play 
a role in postpartum haemorrhage. Higher blood 
loss may be attributed to impaired uterine muscle 
strength for labour when it is prolonged, or de-
creased resistance to infection, as infection is sug-
gested to contribute to uterine dysfunction or in-
ertia (6,7). In our study population, we had a few 
cases of prolonged labour and no cases of uterine 
infection or fever. Decreased uterine blood flow 
or low uterine muscle strength may contribute to 
inefficient uterine contractions and contribute to 
blood loss, potentially mediated by low body iron 
stores (serum ferritin <100 µg/L) and, therefore, 
iron-deficiency anaemia (31,32). Our data are con-
sistent with this latter hypothesis. Severe anaemia 
is hypothesized to impair tolerance of postpartum 
haemorrhage and contribute to maternal death, 
possibly due to the failure of women to endure 
such excessive blood losses and late arrival at ad-
mission (33,34). In our study, the associations be-
tween blood loss and maternal anaemia emanate 
from women with timely hospital admission, nor-
mal labour and delivery, and a few occurrences of 
severe bleeding. These data suggest the influence of 
maternal anaemia on blood loss at childbirth and 
postpartum is more pervasive, affecting blood loss 
across a normal range of losses. Thus, our findings 
are likely to be underestimates of the effect of anae-
mia on blood loss in rural Africa, given the data are 
collected on women residing in town areas with 
hospital-based births, rather than home-based de-
liveries where access to healthcare may be limited, 
and chronic, untreated anaemia is likely to occur.
The present study had several limitations. The rela-
tionship between anaemia and blood loss at child-
birth and postpartum was examined in women 
whose blood loss was reduced by oxytocic drugs, 
limiting the generalizability of our findings. We 
did not determine other measures of iron status or 
markers of infection to conclusively determine iron 
deficiency as the primary cause of anaemia. We 
also had a relatively large loss to follow-up as many 
women did not get to the hospital prior to delivery. 
We chose a hospital-based sample due to ease in 
material collection, processing, and cultural sen-
sitivities to home-based postpartum blood collec-
tion. However, since the majority of African women 
deliver at home due to personal preference, failure 
to seek care, limited access and/or receipt of timely 
obstetric care, our findings require confirmation in 
home-births characterized by little to no manage-
ment of labour and delivery.  Minimal medical care 
may result in an elevated risk for greater blood loss 
and postpartum haemorrhage (35).  
However, given the lack of reliable, high-quality 
data on blood loss at childbirth in sub-Saharan 
Africa where the problem of maternal mortality is 
most acute, these data are an important step in elu-
cidating the impact of anaemia on the health and 
Table 4. Determinants for total blood loss (mL) 
at childbirth and 24 hours postpartum 
estimated  by  multiple  linear  regres-
sion*, n=153, R2=0.27
Independent variable
  Blood loss 
(mL) (SE) p value
Haemoglobin at recruit-
ment
     <90 g/L* 90.6 (28.4) <0.01
     90-110 g/L
     >110 g/L (reference)
11.5 (20.5)
-
0.56
Placental weight 
(per 100 g) 11.0 (5.0) 0.03
First stage of labour 
(hours) 7.1 (2.8) 0.01
Oxytocin received 39.6 (19.7) 0.05
Preterm birth <37 
weeks -52.5 (29.9) 0.08
Parity
  0  (reference) -
  1 34.2 (34.2) 0.32
  2-5 30.3 (33.0) 0.36
  >5 59.6 (35.2) 0.09
Tear 25.0 (37.6) 0.51
Episiotomy 18.8 (34.0) 0.58
Standard Care
Enhanced Care (refer-
ence)
1.9 (19.3)
-
0.92
*Adjusted for socioeconomic factors (pres-
ence of household latrine, ownership of 
motorcycle); SE=Standard errorKavle JA et al. Anaemia during pregnancy and blood loss at delivery
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survival of women. Our findings provide unique 
evidence of a previously-suspected link between 
maternal anaemia and greater blood loss at child-
birth and postpartum. Further research is needed 
to confirm these findings on a larger sample of 
women to determine whether women with moder-
ate-to-severe anaemia are more likely to experience 
postpartum haemorrhage and whether appropriate 
antenatal or peripartum care can affect the relation-
ships described here.
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